Cargando…
Artemisinin‐naphthoquine for treating uncomplicated Plasmodium falciparum malaria
BACKGROUND: The World Health Organization (WHO) recommends artemisinin‐based combination therapy (ACT) for treating people with Plasmodium falciparum malaria. Five combinations are currently recommended, all administered over three days. Artemisinin‐naphthoquine is a new combination developed in Chi...
Autores principales: | Isba, Rachel, Zani, Babalwa, Gathu, Michael, Sinclair, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453860/ https://www.ncbi.nlm.nih.gov/pubmed/25702785 http://dx.doi.org/10.1002/14651858.CD011547 |
Ejemplares similares
-
Dihydroartemisinin‐piperaquine for treating uncomplicated Plasmodium falciparum malaria
por: Zani, Babalwa, et al.
Publicado: (2014) -
A systematic review of the efficacy of a single dose artemisinin–naphthoquine in treating uncomplicated malaria
por: Naing, Cho, et al.
Publicado: (2015) -
Open-label trial of three dosage regimens of fixed-dose combination of artemisinin and naphthoquine for treating uncomplicated falciparum malaria in calabar, Nigeria
por: Meremikwu, Martin M, et al.
Publicado: (2012) -
Artemisinin-naphthoquine combination (ARCO™) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: A preliminary report on safety and efficacy
por: Hombhanje, Francis W, et al.
Publicado: (2009) -
Cost-effectiveness of artemisinin–naphthoquine versus artemether–lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children
por: Moore, Brioni R., et al.
Publicado: (2017)